학술논문

Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium
Document Type
Article
Source
In: Alimentary Pharmacology and Therapeutics. (Alimentary Pharmacology and Therapeutics, May 2024, 59(10):1236-1247)
Subject
Language
English
ISSN
13652036
02692813